Trial Profile
Photodynamic therapy for Lentigo maligna with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA).
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 07 Mar 2016 New trial record